Supplemental figure 2 from A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Autor:	W. Michael Korn, Sanaa Tahiri, Regina Linetskaya, Ryan Courtin, Sharvina Ziyeh, Anna Ong, Elizabeth Dito, Alan P. Venook, R. Kate Kelley, Eric A. Collisson, Margaret A. Tempero, Peter Kuhn, AmirAli Talasaz, Nancy M. Joseph, Olga M. Mirzoeva, Jessica Van Ziffle, Tanios Bekaii-Saab, Andrew H. Ko
Rok vydání:	2023
DOI:	10.1158/1078-0432.22459917
Popis:	Supplemental figure 2. Distribution of proportion of E-cadherin expressing tumor cells across all cases.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f941dd6998462a78f3a157d69c60ce1 https://doi.org/10.1158/1078-0432.22459917 Zobrazit plný text záznamu